The synthesis and biological activity of some known and putative metabolites of the atypical antipsychotic agent olanzapine (LY170053)

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 1, 1997, Pages 25-30

  Calligaro, David O ^a   Fairhurst, John ^a   Hotten, Terrence M ^a   Moore, Nicholas A ^a   Tupper, David E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DRUG METABOLITE; NEUROLEPTIC AGENT; OLANZAPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; REACTION ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031013942     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00567-7     Document Type: Article

References (16)

1. Bymaster, F. P.; Calligaro, D. O.; Falcone, J. F.; Marsh, R. D.; Moore, N. A.; Tye, N. C.; Seeman, P. and Wong, D. T. Neuropsychopharmacol. 1995, In press.
2. Moore, N. A.; Bymaster, F. P.; Calligaro, D. O.; Tye, N. C.; and Wong, D. T. Curr. Opin. Invest, Drugs. 1993. 2(4), 281-293.
3. Beasley, C. B.; Tollefson, G.; Tran, P.; Satterlee, W.; Sanger, T. and Hamilton, S. Neuropsychopharmacol. 1995, In press.
4. Bernstein, J.; Franklin, R.; Gillespie, T.; Kassahun, K.; Mattiuz, E. and Murphy A. 6th North American ISSX Meeting. Raleigh NC, October 1994.
5. Callaghan, J.T.; Gillespie, T.; Kassahun, K.; Mattiuz, E. and Obermeyer, B.D. 6th North American ISSX Meeting. Raleigh NC, October 1994.
6. Luo, H.; Hawes, E. M.; McKay, G.; Midha, K. K. J. Pharm. Sci., 1992, 11, 1079-1083
7. Kassahun, K. Drug Met. &Disp. In press.
8. 13H NMR, MS and IR spectroscopy and had satisfactory microanalyses.
9. Chakrabarti, J. K.; Horsman, L.; Hotten, T. M.; Pullar, I. A.; Tupper D. E. and Wright F. C. J. Med. Chem. 1980, 23, 878-884.
10. D.E. Tupper, F.P. Bymaster, D.O. Calligaro, J. Fairhurst, T.M. Hotten, N.A. Moore and D.T. Wong. Neuroscience Abstracts, 38.6 Washington D.C. 7-12 Nov. 1993 (Poster).
11. Bollenback, G.N.; Long, J.W.; Benjamin, D.G. and Lindquist, J.A. J. Am Chem Soc. 1955, 77, 3310-3315.
12. Moore, N. A. and Axton, M. S. Psychopharmacol. 1988, 94, 263-266.
13. Jacobsen, E. and Sonne, E. Acta Pharmacol. Toxacol. 1955, 11, 135-147.
14. Arnt, J. Pharmacol. et Toxicol. 1982, 51, 321-329.
15. Groups of five animals per dose level.
16. Groups of eight animals per dose level.